We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
351
Freeport-McMoran
FCX
$86.2B
$5.15M 0.03%
103,244
+8,974
+10% +$404K
PCG icon
352
PG&E
PCG
$39B
$5.15M 0.03%
260,332
-10,749
-4% -$201K
COF icon
353
Capital One
COF
$128B
$5.13M 0.03%
34,262
+1,459
+4% +$208K
KDP icon
354
Keurig Dr Pepper
KDP
$42.8B
$5.11M 0.03%
136,353
-32,306
-19% -$1.14M
BHVN icon
355
Biohaven
BHVN
$2.02B
$5M 0.03%
100,000
– –
SNA icon
356
Snap-on
SNA
$21.5B
$4.93M 0.03%
17,015
+10,814
+174% +$2.98M
INFY icon
357
Infosys
INFY
$51B
$4.85M 0.03%
218,000
+66,000
+43% +$1.44M
OKE icon
358
Oneok
OKE
$56.7B
$4.82M 0.03%
52,849
-2,618
-5% -$228K
DHI icon
359
D.R. Horton
DHI
$41.2B
$4.77M 0.03%
25,018
+4,498
+22% +$790K
IOVA icon
360
Iovance Biotherapeutics
IOVA
$2.04B
$4.7M 0.03%
500,033
– –
EOG icon
361
EOG Resources
EOG
$77.7B
$4.69M 0.03%
38,182
+1,443
+4% +$181K
INDA icon
362
iShares MSCI India ETF
INDA
$6.81B
$4.68M 0.03%
80,000
-4,000
-5% -$228K
MKC icon
363
McCormick & Company Non-Voting
MKC
$14B
$4.59M 0.03%
55,765
-1,605
-3% -$125K
FICO icon
364
Fair Isaac
FICO
$31.8B
$4.59M 0.03%
2,361
-228
-9% -$390K
LNG icon
365
Cheniere Energy
LNG
$54.2B
$4.57M 0.03%
25,428
+814
+3% +$146K
LBTYA icon
366
Liberty Global Class A
LBTYA
$3.59B
$4.56M 0.03%
+216,153
New +$4.17M
APH icon
367
Amphenol
APH
$185B
$4.54M 0.03%
69,699
+2,007
+3% +$130K
KYMR icon
368
Kymera Therapeutics
KYMR
$8.66B
$4.54M 0.03%
95,821
-142,344
-60% -$6.29M
AYI icon
369
Acuity Brands
AYI
$9.99B
$4.53M 0.03%
+16,446
New +$4.09M
RUN icon
370
Sunrun
RUN
$2.26B
$4.53M 0.03%
250,605
+34,200
+16% +$608K
NEM icon
371
Newmont
NEM
$96.2B
$4.5M 0.03%
84,209
+8,192
+11% +$407K
APO icon
372
Apollo Global Management
APO
$69B
$4.47M 0.03%
35,824
-127,178
-78% -$14.7M
AVB icon
373
AvalonBay Communities
AVB
$27.5B
$4.46M 0.03%
19,797
+1,279
+7% +$276K
ES icon
374
Eversource Energy
ES
$28.1B
$4.46M 0.03%
65,490
+642
+1% +$41.5K
SUPN icon
375
Supernus Pharmaceuticals
SUPN
$2.7B
$4.42M 0.03%
141,889
– –
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.